SCHEMBL8902168

SCHEMBL8902168

COc1ccc(OC)c2c1COC(CCOC(O)OC)C2

nearest known ligand 0.37

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8528876 0.76 ADRA1A (0.46) ADRA1A
SCHEMBL8527998 0.74 ADRA1A (0.47) ADRA1A
SCHEMBL27354246 0.73 ADRA1A (0.46) ADRA1A
SCHEMBL8528043 0.73 ADRA1A (0.46) ADRA1A
SCHEMBL8527972 0.71 ADRA1A (0.41) ADRA1A
SCHEMBL8531946 0.70 ADRA1A (0.42) ADRA1A
SCHEMBL8527531 0.68 MTNR1A (0.52)
SCHEMBL8528640 0.67 TDP1 (0.51) ADRA1A
SCHEMBL8530552 0.65 ADRA1A (0.47) ADRA1A
SCHEMBL8529815 0.64 ADRA1A (0.46) ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5593970-A ANTITUMOR AND ANTCARCINOGENIC AGENTS; TRETMENT OF CANCEROUS BONE MARROW BEFORE REGRAFTING BIOCHEM PHARMA INC. (CA) 1997-01-14 US disclosed
WO-1991019725-A2 HETEROCYCLIC ANTHRACYCLIONE AND ANTHRACYCLINE ANALOGS BIOCHEM PHARMA INC. (CA) 1991-12-26 WO disclosed